REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Anygen Co.,Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Anygen Co.,Ltd. Profile Updated: July 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Anygen Company is a manufacturer of Generic Peptide in the pharmaceutical industry. The company offers products produced in GMP facilities and targets the market for affordable peptide solutions.

Headquarters
206, Gwangju Technopark, 333, Cheomdangwagi-Ro, Buk-Gu, Gwangju
Gwangju; Gyeonggi;

Contact Details: Purchase the Anygen Co.,Ltd. report to view the information.

Website: http://www.anygen.com

Basic Information
Total Employees:
Purchase the Anygen Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Anygen Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Anygen Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Anygen Co.,Ltd. report to view the information.
Incorporation Date:
May 02, 2000
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
18.8%
Purchase this report to view the information.
0.2%
Purchase this report to view the information.
0.1%
Subsidiaries
애니젠(주)
Company Performance
Financial values in the chart are available after Anygen Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
47.95%▲
Total operating revenue
47.88%▲
Operating profit (EBIT)
-30.13%▼
EBITDA
-243.58%▼
Net Profit (Loss) for the Period
-12.03%▼
Total assets
-30.6%▼
Total equity
-24.41%▼
Operating Profit Margin (ROS)
6.13%▲
Net Profit Margin
15.49%▲
Return on Equity (ROE)
-4.23%▼
Debt to Equity Ratio
-24.5%▼
Quick Ratio
-0.16%▼
Cash Ratio
-0.03%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo